Back
Hepion Pharmaceuticals Stock Price Chart
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
5
HEPA
Hepion Pharmaceuticals
Last Price:
1.39
Seasonality Move:
-13.18%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing slight selling pressure.
Hepion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.73 | Sell |
| 20-day SMA: | 2.13 | Sell |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 4.14 | Sell |
| 8-day EMA: | 1.65 | Sell |
| 20-day EMA: | 1.96 | Sell |
| 50-day EMA: | 2.21 | Sell |
| 200-day EMA: | 4.48 | Sell |
Hepion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 26.81 | Sell |
| Chaikin Money Flow: | -11482 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.78 - 2.54) | Sell |
| Bollinger Bands (100): | (1.86 - 3.12) | Sell |
Hepion Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hepion Pharmaceuticals Stock
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 1.29 while HEPA 8-day simple moving average is 1.73, which is a Sell signal.
- The stock price of HEPA is 1.29 while Hepion Pharmaceuticals 20-day SMA is 2.13, which makes it a Sell.
- Hepion Pharmaceuticals 50-day simple moving average is 2.29 while HEPA share price is 1.29, making it a Sell technically.
- HEPA stock price is 1.29 and Hepion Pharmaceuticals 200-day simple moving average is 4.14, creating a Sell signal.
HEPA Technical Analysis vs Fundamental Analysis
Sell
5
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a Sell
The current Hepion Pharmaceuticals [HEPA] share price is $1.29. The Score for HEPA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
Hepion Pharmaceuticals Stock Info
Market Cap:
7.06M
Price in USD:
1.29
Share Volume:
22.99K
Hepion Pharmaceuticals 52-Week Range
52-Week High:
20.66
52-Week Low:
1.22
Sell
5
Hepion Pharmaceuticals (HEPA)
is a Sell
Hepion Pharmaceuticals Share Price Forecast
-
What is the Hepion Pharmaceuticals stock price today?
The Hepion Pharmaceuticals stock price is 1.29 USD today. -
Will HEPA stock go up or go down?
Hepion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Hepion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hepion Pharmaceuticals is overvalued.
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 1.29 while HEPA 8-day exponential moving average is 1.65, which is a Sell signal.
- The stock price of HEPA is 1.29 while Hepion Pharmaceuticals 20-day EMA is 1.96, which makes it a Sell.
- Hepion Pharmaceuticals 50-day exponential moving average is 2.21 while HEPA share price is 1.29, making it a Sell technically.
- HEPA stock price is 1.29 and Hepion Pharmaceuticals 200-day simple moving average is 4.48, creating a Sell signal.
Fundamental Analysis of Hepion Pharmaceuticals
Is Hepion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Hepion Pharmaceuticals
Should I short Hepion Pharmaceuticals stock?
- HEPA Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Hepion Pharmaceuticals is a Sell
- Hepion Pharmaceuticals Relative Strength Index (RSI) is 26.81, which suggest Hepion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Hepion Pharmaceuticals is (1.78 - 2.54), which suggest Hepion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Hepion Pharmaceuticals is (1.86 - 3.12), which suggest Hepion Pharmaceuticals is a Sell
* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.